1. Rizek RL, Friend B, Page L. Fat in todays food supply—level of use and sources. J Am Oil Chem Soc1974;51:244–50. 10.1007/BF02642629 [PubMed] [CrossRef] [Google Scholar]
2. Guyenet SJ, Carlson SE. Increase in adipose tissue linoleic acid of US adults in the last half century. Adv Nutr2015;6:660–4. 10.3945/an.115.009944 [PMC free article] [PubMed] [CrossRef] [Google Scholar]
3. Hodgson JM, Wahlqvist ML, Boxall JA, et al.. Can linoleic acid contribute to coronary artery disease?Am J Clin Nutr1993;58:228–34. 10.1093/ajcn/58.2.228 [PubMed] [CrossRef] [Google Scholar]
4. Schwertner HA, Mosser EL. Comparison of lipid fatty acids on a concentration basis vs weight percentage basis in patients with and without coronary artery disease or diabetes. Clin Chem1993;39:659–63. [PubMed] [Google Scholar]
5. Gumbiner B, Low CC, Reaven PD. Effects of a monounsaturated fatty acid-enriched hypocaloric diet on cardiovascular risk factors in obese patients with type 2 diabetes. Diabetes Care1998;21:9–15. 10.2337/diacare.21.1.9 [PubMed] [CrossRef] [Google Scholar]
6. Silaste ML, Rantala M, Alfthan G, et al.. Changes in dietary fat intake alter plasma levels of oxidized low-density lipoprotein and lipoprotein(a). Arterioscler Thromb Vasc Biol2004;24:498–503. 10.1161/01.ATV.0000118012.64932.f4 [PubMed] [CrossRef] [Google Scholar]
7. Holvoet P, Vanhaecke J, Janssens S, et al.. Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease. Circulation1998;98:1487–94. 10.1161/01.CIR.98.15.1487 [PubMed] [CrossRef] [Google Scholar]
8. Holvoet P, Stassen JM, Van Cleemput J, et al.. Oxidized low density lipoproteins in patients with transplant-associated coronary artery disease. Arterioscler Thromb Vasc Biol1998;18:100–7. 10.1161/01.ATV.18.1.100 [PubMed] [CrossRef] [Google Scholar]
9. Salonen JT, Ylä-Herttuala S, Yamamoto R, et al.. Autoantibody against oxidised LDL and progression of carotid atherosclerosis. Lancet1992;339:883–7. 10.1016/0140-6736(92)90926-T [PubMed] [CrossRef] [Google Scholar]
10. Ylä-Herttuala S, Palinski W, Rosenfeld ME, et al.. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest1989;84:1086–95. 10.1172/JCI114271 [PMC free article] [PubMed] [CrossRef] [Google Scholar]
11. Palinski W, Ylä-Herttuala S, Rosenfeld ME, et al.. Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein. Arteriosclerosis1990;10:325–35. 10.1161/01.ATV.10.3.325 [PubMed] [CrossRef] [Google Scholar]
12. Palinski W, Ord VA, Plump AS, et al.. ApoE-deficient mice are a model of lipoprotein oxidation in atherogenesis. Demonstration of oxidation-specific epitopes in lesions and high titers of autoantibodies to malondialdehyde-lysine in serum. Arterioscler Thromb1994;14:605–16. 10.1161/01.ATV.14.4.605 [PubMed] [CrossRef] [Google Scholar]
13. Parthasarathy S, Litvinov D, Selvarajan K, et al.. Lipid peroxidation and decomposition—conflicting roles in plaque vulnerability and stability. Biochim Biophys Acta2008;1781:221–31. 10.1016/j.bbalip.2008.03.002 [PMC free article] [PubMed] [CrossRef] [Google Scholar]
14. Jira W, Spiteller G, Carson W, et al.. Strong increase in hydroxy fatty acids derived from linoleic acid in human low density lipoproteins of atherosclerotic patients. Chem Phys Lipids1998;91:1–11. 10.1016/S0009-3084(97)00095-9 [PubMed] [CrossRef] [Google Scholar]
15. Haberland ME, Olch CL, Folgelman AM. Role of lysines in mediating interaction of modified low density lipoproteins with the scavenger receptor of human monocyte macrophages. J Biol Chem1984;259:11305–11. [PubMed] [Google Scholar]
16. Haberland ME, Fogelman AM, Edwards PA. Specificity of receptor-mediated recognition of malondialdehyde-modified low density lipoproteins. Proc Natl Acad Sci U S A1982;79:1712–6. 10.1073/pnas.79.6.1712 [PMC free article] [PubMed] [CrossRef] [Google Scholar]
17. Young IS, McFarlane C, McEneny J. Oxidative modification of triacylglycerol-rich lipoproteins. Biochem Soc Trans2003;31(Pt 5):1062–5. 10.1042/bst0311062 [PubMed] [CrossRef] [Google Scholar]
18. Francis GA.High density lipoprotein oxidation: in vitro susceptibility and potential in vivo consequences. Biochim Biophys Acta2000;1483:217–35. 10.1016/S1388-1981(99)00181-X [PubMed] [CrossRef] [Google Scholar]
19. Shao B, Oda MN, Vaisar T, et al.. Pathways for oxidation of high-density lipoprotein in human cardiovascular disease. Curr Opin Mol Ther2006;8:198–205. [PubMed] [Google Scholar]
20. Reaven P, Parthasarathy S, Grasse BJ, et al.. Effects of oleate-rich and linoleate-rich diets on the susceptibility of low density lipoprotein to oxidative modification in mildly hypercholesterolemic subjects. J Clin Invest1993;91:668–76. 10.1172/JCI116247 [PMC free article] [PubMed] [CrossRef] [Google Scholar]
21. Belkner J, Wiesner R, Kühn H, et al.. The oxygenation of cholesterol esters by the reticulocyte lipoxygenase. FEBS Lett1991;279:110–4. 10.1016/0014-5793(91)80263-3 [PubMed] [CrossRef] [Google Scholar]
22. Brooks CJ, Harland WA, Steel G, et al.. Lipids of human atheroma: isolation of hydroxyoctade cadienoic acids from advanced aortal lesions. Biochim Biophys Acta1970;202:563–6. 10.1016/0005-2760(70)90131-1 [PubMed] [CrossRef] [Google Scholar]
23. Harland WA, Gilbert JD, Steel G, et al.. Lipids of human atheroma. 5. The occurrence of a new group of polar sterol esters in various stages of human atherosclerosis. Atherosclerosis1971;13:239–46. 10.1016/0021-9150(71)90026-8 [PubMed] [CrossRef] [Google Scholar]
24. Brooks CJ, Steel G, Gilbert JD, et al.. Lipids of human atheroma. 4. Characterisation of a new group of polar sterol esters from human atherosclerotic plaques. Atherosclerosis1971;13:223–37. 10.1016/0021-9150(71)90025-6 [PubMed] [CrossRef] [Google Scholar]
25. Glavind J, Hartmann S, Clemmesen J, et al.. Studies on the role of lipoperoxides in human pathology. II. The presence of peroxidized lipids in the atherosclerotic aorta. Acta Pathol Microbiol Scand1952;30:1–6. [PubMed] [Google Scholar]
26. Wang T, Powell WS. Increased levels of monohydroxy metabolites of arachidonic acid and linoleic acid in LDL and aorta from atherosclerotic rabbits. Biochim Biophys Acta1991;1084:129–38. 10.1016/0005-2760(91)90211-Y [PubMed] [CrossRef] [Google Scholar]
27. Halliwell B, Grootveld M. The measurement of free radical reactions in humans. Some thoughts for future experimentation. FEBS Lett1987;213:9–14. [PubMed] [Google Scholar]
28. Steinbrecher UP, Parthasarathy S, Leake DS, et al.. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc Natl Acad Sci U S A1984;81:3883–7. 10.1073/pnas.81.12.3883 [PMC free article] [PubMed] [CrossRef] [Google Scholar]
29. Morel DW, DiCorleto PE, Chisolm GM. Endothelial and smooth muscle cells alter low density lipoprotein in vitro by free radical oxidation. Arteriosclerosis1984;4:357–64. 10.1161/01.ATV.4.4.357 [PubMed] [CrossRef] [Google Scholar]
30. Miyazawa T, Fujimoto K, Oikawa S. Determination of lipid hydroperoxides in low density lipoprotein from human plasma using high performance liquid chromatography with chemiluminescence detection. Biomed Chromatogr1990;4:131–4. 10.1002/bmc.1130040312 [PubMed] [CrossRef] [Google Scholar]
31. Miyazawa T.Determination of phospholipid hydroperoxides in human blood plasma by a chemiluminescence-HPLC assay. Free Radic Biol Med1989;7:209–18. 10.1016/0891-5849(89)90017-8 [PubMed] [CrossRef] [Google Scholar]
32. Miyazawa T, Yasuda K, Fujimoto K, et al.. Presence of phosphatidylcholine hydroperoxide in human plasma. J Biochem1988;103:744–6. 10.1093/oxfordjournals.jbchem.a122339 [PubMed] [CrossRef] [Google Scholar]
33. Wang L, Gill R, Pedersen TL, et al.. Triglyceride-rich lipoprotein lipolysis releases neutral and oxidized FFAs that induce endothelial cell inflammation. J Lipid Res2009;50:204–13. 10.1194/jlr.M700505-JLR200 [PMC free article] [PubMed] [CrossRef] [Google Scholar]
34. Eiselein L, Wilson DW, Lamé MW, et al.. Lipolysis products from triglyceride-rich lipoproteins increase endothelial permeability, perturb zonula occludens-1 and F-actin, and induce apoptosis. Am J Physiol Heart Circ Physiol2007;292:H2745–53. 10.1152/ajpheart.00686.2006 [PubMed] [CrossRef] [Google Scholar]
35. Hennig B, Shasby DM, Spector AA. Exposure to fatty acid increases human low density lipoprotein transfer across cultured endothelial monolayers. Circ Res1985;57:776–80. 10.1161/01.RES.57.5.776 [PubMed] [CrossRef] [Google Scholar]
36. Bemelmans WJ, Lefrandt JD, Feskens EJ, et al.. Increased alpha-linolenic acid intake lowers C-reactive protein, but has no effect on markers of atherosclerosis. Eur J Clin Nutr2004;58:1083–9. 10.1038/sj.ejcn.1601938 [PubMed] [CrossRef] [Google Scholar]
37. Bemelmans WJ, Broer J, Feskens EJ, et al.. Effect of an increased intake of alpha-linolenic acid and group nutritional education on cardiovascular risk factors: the Mediterranean Alpha-Linolenic Enriched Groningen Dietary Intervention (MARGARIN) study. Am J Clin Nutr2002;75:221–7. 10.1093/ajcn/75.2.221 [PubMed] [CrossRef] [Google Scholar]
38. Mozaffarian D, Rimm EB, Herrington DM. Dietary fats, carbohydrate, and progression of coronary atherosclerosis in postmenopausal women. Am J Clin Nutr2004;80:1175–84. 10.1093/ajcn/80.5.1175 [PMC free article] [PubMed] [CrossRef] [Google Scholar]
39. Erkkilä AT, Lichtenstein AH, Mozaffarian D, et al.. Fish intake is associated with a reduced progression of coronary artery atherosclerosis in postmenopausal women with coronary artery disease. Am J Clin Nutr2004;80:626–32. 10.1093/ajcn/80.3.626 [PubMed] [CrossRef] [Google Scholar]
40. Christakis G, Rinzler SH, Archer M, et al.. Effect of the anti-coronary club program on coronary heart disease. Risk-factor status. JAMA1966;198:597–604. 10.1001/jama.1966.03110190079022 [PubMed] [CrossRef] [Google Scholar]
41. Ramsden CE, Zamora D, Leelarthaepin B, et al.. Use of dietary linoleic acid for secondary prevention of coronary heart disease and death: evaluation of recovered data from the Sydney Diet Heart Study and updated meta-analysis. BMJ2013;346:e8707 10.1136/bmj.e8707 [PMC free article] [PubMed] [CrossRef] [Google Scholar]
42. Ramsden CE, Zamora D, Majchrzak-Hong S, et al.. Re-evaluation of the traditional diet-heart hypothesis: analysis of recovered data from Minnesota Coronary Experiment (1968-73). BMJ2016;353:i1246 10.1136/bmj.i1246 [PMC free article] [PubMed] [CrossRef] [Google Scholar]
43. Ramsden CE, Hibbeln JR, Majchrzak SF, et al.. n-6 fatty acid-specific and mixed polyunsaturate dietary interventions have different effects on CHD risk: a meta-analysis of randomised controlled trials. Br J Nutr2010;104:1586–600. 10.1017/S0007114510004010 [PMC free article] [PubMed] [CrossRef] [Google Scholar]
44. Dudda A, Spiteller G, Kobelt F. Lipid oxidation products in ischemic porcine heart tissue. Chem Phys Lipids1996;82:39–51. 10.1016/0009-3084(96)02557-1 [PubMed] [CrossRef] [Google Scholar]
45. Jira W, Spiteller G, Richter A. Increased levels of lipid oxidation products in low density lipoproteins of patients suffering from rheumatoid arthritis. Chem Phys Lipids1997;87:81–9. 10.1016/S0009-3084(97)00030-3 [PubMed] [CrossRef] [Google Scholar]
46. Regnström J, Nilsson J, Tornvall P, et al.. Susceptibility to low-density lipoprotein oxidation and coronary atherosclerosis in man. Lancet1992;339:1183–6. 10.1016/0140-6736(92)91129-V [PubMed] [CrossRef] [Google Scholar]
47. Rolin J, Vego H, Maghazachi AA. Oxidized lipids and lysophosphatidylcholine induce the chemotaxis, up-regulate the expression of CCR9 and CXCR4 and abrogate the release of IL-6 in human monocytes. Toxins2014;6:2840–56. 10.3390/toxins6092840 [PMC free article] [PubMed] [CrossRef] [Google Scholar]
48. Binder CJ.Naturally occurring IgM antibodies to oxidation-specific epitopes. Adv Exp Med Biol2012;750:2–13. 10.1007/978-1-4614-3461-0_1 [PubMed] [CrossRef] [Google Scholar]
49. Rolin J, Al-Jaderi Z, Maghazachi AA. Oxidized lipids and lysophosphatidylcholine induce the chemotaxis and intracellular calcium influx in natural killer cells. Immunobiology2013;218:875–83. 10.1016/j.imbio.2012.10.009 [PubMed] [CrossRef] [Google Scholar]
50. Lawrie TD, McAlpine SG, Rifkind BM, et al.. A comparison of serum lipoprotein and aortic plaque fatty acids. Clin Sci1964;27:89–96. [PubMed] [Google Scholar]
51. Carpenter KL, Taylor SE, Ballantine JA, et al.. Lipids and oxidised lipids in human atheroma and normal aorta. Biochim Biophys Acta1993;1167:121–30. 10.1016/0005-2760(93)90151-X [PubMed] [CrossRef] [Google Scholar]
52. Dayton S, Hashimoto S, Pearce ML. Influence of a diet high in unsaturated fat upon composition of arterial tissue and atheromata in man. Circulation1965;32:911–24. 10.1161/01.CIR.32.6.911 [PubMed] [CrossRef] [Google Scholar]
53. Wan JB, Huang LL, Rong R, et al.. Endogenously decreasing tissue n-6/n-3 fatty acid ratio reduces atherosclerotic lesions in apolipoprotein E-deficient mice by inhibiting systemic and vascular inflammation. Arterioscler Thromb Vasc Biol2010;30:2487–94. 10.1161/ATVBAHA.110.210054 [PubMed] [CrossRef] [Google Scholar]
54. Wang HH, Hung TM, Wei J, et al.. Fish oil increases antioxidant enzyme activities in macrophages and reduces atherosclerotic lesions in apoE-knockout mice. Cardiovasc Res2004;61:169–76. 10.1016/j.cardiores.2003.11.002 [PubMed] [CrossRef] [Google Scholar]
55. Thies F, Garry JM, Yaqoob P, et al.. Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial. Lancet2003;361:477–85. 10.1016/S0140-6736(03)12468-3 [PubMed] [CrossRef] [Google Scholar]
56. Marchix J, Choque B, Kouba M, et al.. Excessive dietary linoleic acid induces proinflammatory markers in rats. J Nutr Biochem2015;26:1434–41. 10.1016/j.jnutbio.2015.07.010 [PubMed] [CrossRef] [Google Scholar]
57. Hennig B, Meerarani P, Ramadass P, et al.. Fatty acid-mediated activation of vascular endothelial cells. Metabolism2000;49:1006–13. 10.1053/meta.2000.7736 [PubMed] [CrossRef] [Google Scholar]
58. Toborek M, Hennig B. The role of linoleic acid in endothelial cell gene expression. Relationship to atherosclerosis. Subcell Biochem1998;30:415–36. [PubMed] [Google Scholar]
59. Toborek M, Lee YW, Garrido R, et al.. Unsaturated fatty acids selectively induce an inflammatory environment in human endothelial cells. Am J Clin Nutr2002;75:119–25. 10.1093/ajcn/75.1.119 [PubMed] [CrossRef] [Google Scholar]
60. Harrell MD, Stimers JR. Differential effects of linoleic acid metabolites on cardiac sodium current. J Pharmacol Exp Ther2002;303:347–55. 10.1124/jpet.102.038166 [PubMed] [CrossRef] [Google Scholar]
61. Luostarinen R, Boberg M, Saldeen T. Fatty acid composition in total phospholipids of human coronary arteries in sudden cardiac death. Atherosclerosis1993;99:187–93. 10.1016/0021-9150(93)90021-L [PubMed] [CrossRef] [Google Scholar]
62. Mensink RP, Katan MB. Effect of dietary fatty acids on serum lipids and lipoproteins. A meta-analysis of 27 trials. Arterioscler Thromb1992;12:911–9. 10.1161/01.ATV.12.8.911 [PubMed] [CrossRef] [Google Scholar]
63. Parthasarathy S, Khoo JC, Miller E, et al.. Low density lipoprotein rich in oleic acid is protected against oxidative modification: implications for dietary prevention of atherosclerosis. Proc Natl Acad Sci U S A1990;87:3894–8. 10.1073/pnas.87.10.3894 [PMC free article] [PubMed] [CrossRef] [Google Scholar]
64. Hartwich J, Malec MM, Partyka L, et al.. The effect of the plasma n-3/n-6 polyunsaturated fatty acid ratio on the dietary LDL phenotype transformation—insights from the LIPGENE study. Clin Nutr2009;28:510–5. 10.1016/j.clnu.2009.04.016 [PubMed] [CrossRef] [Google Scholar]
65. Griffin MD, Sanders TA, Davies IG, et al.. Effects of altering the ratio of dietary n-6 to n-3 fatty acids on insulin sensitivity, lipoprotein size, and postprandial lipemia in men and postmenopausal women aged 45–70 y: the OPTILIP Study. Am J Clin Nutr2006;84:1290–8. 10.1093/ajcn/84.6.1290 [PubMed] [CrossRef] [Google Scholar]
66. Nilsen DW, Albrektsen G, Landmark K, et al.. Effects of a high-dose concentrate of n-3 fatty acids or corn oil introduced early after an acute myocardial infarction on serum triacylglycerol and HDL cholesterol. Am J Clin Nutr2001;74:50–6. 10.1093/ajcn/74.1.50 [PubMed] [CrossRef] [Google Scholar]
